Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro By Angelica Peebles, CNBC • Published April 23, 2025 • Updated on April 23, 2025 at 6:04 pm ...

HAYA Therapeutics Moves San Diego Operations to Lilly Gateway Labs® to Accelerate Development of RNA-Guided Therapeutics Platform Provided by Business Wire Jun 3, 2025, 5:02:00 AM ...

Eli Lilly and Company World Headquarters. (Jonathan Weiss/JetCity Image/Dreamstime/TN) By Paul Sisson | [email protected] | The San Diego Union-Tribune UPDATED: June 23, 2025 at 5:58 ...

Reuters FILE PHOTO: Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023, after Eli Lilly and Co on Wednesday said it will cut list prices by 70% for its most commonly ...

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of tirzepatide, the active ingredient in Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro.